Replies to post #7541 on Momenta Pharmaceuticals, Inc. (MNTA)

[iwfal]

Today’s agreement on the Court-ordered bond and related liabilities does not in any way change NVS-MNTA’s agreement on dividing the proceeds from sales of generic Lovenox.

Self evidently true - but probably equally true that Momenta wouldn't agree to take on a percentage liability significantly different than their expected benefit if MNTA/NVS prevail. I.e. if MNTA expects to get only 10% of the expected NPV of additional cash flow when NVS/MNTA prevail then I wouldn't expect them to take on 50% of the liability should NVS/MNTA lose.